Brainspotting
Brainspotting is a trauma-focused psychotherapy developed by David Grand in 2003. Its core mechanism: holding a fixed eye position is proposed to access subcortical processing of trauma 'capsules'; therapist attunement supports activation and discharge (mechanism unestablished). This catalogue links it to PTSD, complex trauma and anxiety, typically in individual format, short-medium.
Related condition topics
These links support exploration. They do not establish that Brainspotting is effective or recommended for each condition.
How Brainspotting works
Holding a fixed eye position is proposed to access subcortical processing of trauma 'capsules'; therapist attunement supports activation and discharge (mechanism unestablished)
Ontology
Trauma stored subcortically in body/brain; accessed through visual field-somatic connection
Therapeutic Voice
"Just notice where your eyes naturally want to go when you hold that feeling. Stay there."
View of the Person
A being whose trauma lives subcortically in the body-brain, accessible through the visual field
Epistemology
Evidence
Assessment not yet completed
An overall effectiveness assessment has not been completed. This describes the state of our review, not whether the approach works.
Recorded material under review
The existing notes below are retained separately from assessment records. These recorded claims await source checking, including study design, recommendations and numerical estimates.
Not listed in any major guidelines
3-5 small RCTs
No meta-analysis
Very limited controlled evidence. Hildebrand et al. (2017) small RCT showed large effect. Much more research needed.
Training and certification
Licensed mental health professional. Sequential phase training (Phase 1 prerequisite for all subsequent phases). Can practice after Phase 1. Certification requires Phase 1, Phase 2, one advanced training, 50 documented sessions, and 6 consultation hours with an Approved Consultant.
Brainspotting Trainings, LLC: Certified Brainspotting Practitioner, renewed every 2 years. Approved Brainspotting Consultant is a further tier requiring 1 year certified plus 3 of 4 advanced trainings with David Grand.
Phase 1: ~21 hrs (3 days); Phases 2–5 each ~21 hrs. Certification path: ~63 training hrs plus 50 documented sessions and 6 consultation hrs. Full 5-phase path: 100+ hrs.
$500–800 per phase; full 5-phase path: $2.5K–4K
Find a trained therapist
Clinical cautions and blind spots
Assessment and precautions
Active psychosis, unstable dissociative disorders, active suicidality, seizure disorders without clearance, clients without adequate emotional regulation capacity for trauma processing
Blind spots
Very limited controlled research; proposed mechanisms largely speculative; certification and consultant approval are administered by the founder's own training company with no independent accrediting body
Philosophical roots
Merleau-Ponty (body-subject, perception); Levine (somatic trauma); Damasio (somatic marker hypothesis); Grand (subcortical processing thesis)
Origins & Influences
Brainspotting is a hybrid. David Grand, trained in psychoanalysis in the 1980s and EMDR in 1993, encountered Peter Levine's Somatic Experiencing in 1999 and began integrating all three into what he called 'Natural Flow EMDR': slowed-down eye movements, body resourcing borrowed from SE, and relational attunement from his psychoanalytic background. The breakthrough came in 2003 when a client (a figure skater with dissociative performance issues) held a fixed eye position during an EMDR session and accessed material that had never surfaced. Grand realized the fixed gaze was doing something different from bilateral movement. Brainspotting's mechanism remains debated. Grand posits subcortical processing via the visual field; critics suggest the active ingredients may be exposure, therapeutic relationship, and focused attention rather than anything specific to eye position. Ecker and colleagues' memory reconsolidation framework (from Coherence Therapy) offers a third explanation: the fixed gaze may facilitate the retrieval and reactivation of implicit emotional learnings in a way that opens a reconsolidation window: the focused activation plus the safety of the therapeutic relationship providing the 'mismatch experience' that allows the brain to update the original encoding. If Brainspotting produces reliable effects, this would account for them without requiring Grand's subcortical hypothesis to be correct.
Compared with other approaches
Controversies
Characterized as pseudoscience in peer-reviewed analysis (McKay & Coreil, 2024); no plausible neural mechanism; very limited controlled research
McKay and Coreil (2024) published a formal analysis in Medical Hypotheses concluding that Brainspotting meets established criteria for pseudoscience: model loopholes preventing falsification, emphasis on confirmation over disconfirmation, overreliance on anecdotal evidence and case reports, excessive ‘science-ism’ (claiming dramatic brain connectivity where none plausibly exists), and built-in insulation from disconfirmation. The authors found no evidence that the proposed neural circuitry is involved in posttraumatic stress or traumatic memories.
Brainspotting proponents argue that clinical outcomes support the approach regardless of whether mechanisms are fully understood. David Grand and practitioners point to growing clinical adoption (13,000+ trained therapists) and emerging pilot studies.
Steven Novella at Science-Based Medicine characterized Brainspotting as ‘classic pseudoscience,’ noting that the claimed midbrain maps to specific eye positions and subsequently to traumatic memories have no neuroanatomical basis, and that Grand has had 23 years to produce rigorous evidence but has focused on building a treatment brand rather than testing underlying principles.
Brainspotting proponents counter that the demand for large RCTs reflects a funding bias: unlike pharmaceutical-backed treatments, practitioner-developed therapies lack corporate research budgets. A 2023 RCT (Horton et al.) found BSP superior to treatment-as-usual for PTSD, and a 2017 comparative study (Hildebrand et al.) found BSP comparable to EMDR, though critics note Grand co-authored the latter.
Lilienfeld et al. (2015) included Brainspotting among questionable and controversial treatments for trauma in the Canadian Journal of Psychiatry, noting claims based on ‘scientifically dubious assumptions’ about aversive experiences being banished from consciousness.
Brainspotting practitioners note that Lilienfeld's 2015 critique predates subsequent pilot studies and the 2023 Horton et al. RCT. They argue the characterization grouped BSP with demonstrably harmful practices, which they consider unfair for an approach with emerging positive outcome data.
Context: EMDR faced nearly identical criticisms in its first two decades (implausible mechanism, origin in a single anecdotal observation, founder-led research, and accusations of pseudoscience) before accumulating enough independent RCTs to earn guideline status. Whether Brainspotting follows the same trajectory or remains unsupported is an open question. As of 2025, BSP has one independent RCT (Horton et al., 2023) and several pilot studies, while EMDR had a comparable evidence base at a similar point in its development.
Test Yourself
What is 'dual attunement'?
Show answer
Simultaneously attuning to the relational field and the client's neurobiological process.